🟢 A is trading 12% up today after completing Biocare Medical acquisition

A is trading 12% up at $152.39 after announcing it has completed the acquisition of Biocare Medical, a leader in clinical pathology.

• The $950 million deal is expected to enhance the company's pathology portfolio and accelerate innovation.
• Management expects the acquisition to be accretive to growth and margins within the first year.
• The strategic move is boosting investor sentiment as it strengthens the company's position in the clinical pathology market.